Aura Biosciences, Inc.
AURA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501796
No open-market purchases or sales by Aura Biosciences, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $677.2M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Aura Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 49
- +6 vs. Q3 2022
- Shares held
- 23.8M
- +7.49M (+45.9%) vs. Q3 2022
- Total value
- $250.0M
- −$45.6M (−15.4%) vs. Q3 2022
- New holders
- 12
- 21 more added
- Sold out
- 6
- 10 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 146 | $677.2M |
| Q1 2026 | 126 | $340.3M |
| Q4 2025 | 117 | $273.8M |
| Q3 2025 | 106 | $319.2M |
| Q2 2025 | 105 | $316.9M |
| Q1 2025 | 94 | $231.5M |
| Q4 2024 | 94 | $324.3M |
| Q3 2024 | 81 | $329.2M |
| Q2 2024 | 75 | $300.4M |
| Q1 2024 | 78 | $307.1M |
| Q4 2023 | 72 | $327.8M |
| Q3 2023 | 64 | $254.4M |
| Q2 2023 | 59 | $334.4M |
| Q1 2023 | 57 | $232.6M |
| Q4 2022 | 49 | $250.0M |
| Q3 2022 | 43 | $295.7M |
| Q2 2022 | 44 | $223.8M |
| Q1 2022 | 34 | $298.8M |
| Q4 2021 | 32 | $220.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aura Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Matrix Capital Management Company, LP | 5,362,870 | $56.3M | 1.07% | +1,250,000+30.4% | Added |
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $31.9M | 13.41% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,737,053 | $28.7M | 0.03% | +424,735+18.4% | Added |
| Eventide Asset Management, LLC | 2,251,368 | $23.6M | 0.47% | +2,251,368 | New |
| Adage Capital Partners GP, L.L.C. | 2,132,739 | $22.4M | 0.05% | +681,538+47.0% | Added |
| BlackRock Inc. | 1,053,127 | $11.1M | 0.00% | +39,672+3.9% | Added |
| Rock Springs Capital Management LP | 1,019,757 | $10.7M | 0.26% | +4,000+0.4% | Added |
| Vanguard Group Inc | 863,580 | $9.07M | 0.00% | +257,696+42.5% | Added |
| Nantahala Capital Management, LLC | 798,751 | $8.39M | 0.76% | +414,987+108.1% | Added |
| Price T Rowe Associates Inc | 739,215 | $7.76M | 0.00% | +739,215 | New |
| FMR LLC | 728,397 | $7.65M | 0.00% | +124,636+20.6% | Added |
| Regency Capital Management Inc. | 554,286 | $5.82M | 6.69% | +329,732+146.8% | Added |
| Artal Group S.A. | 410,000 | $4.30M | 0.25% | +410,000 | New |
| State Street Corp | 310,690 | $3.26M | 0.00% | +12,252+4.1% | Added |
| Geode Capital Management, LLC | 300,473 | $3.15M | 0.00% | +11,161+3.9% | Added |
| Decheng Capital Management III (Cayman), LLC | 293,333 | $3.08M | 1.15% | +83,333+39.7% | Added |
| Goldman Sachs Group Inc | 205,580 | $2.16M | 0.00% | +205,580 | New |
| Citigroup Inc | 145,704 | $1.53M | 0.00% | −4,036−2.7% | Reduced |
| Northern Trust Corp | 143,815 | $1.51M | 0.00% | −1,286−0.9% | Reduced |
| Monashee Investment Management LLC | 131,640 | $1.38M | 0.59% | +131,640 | New |
| Morgan Stanley | 64,603 | $678.3K | 0.00% | +9,451+17.1% | Added |
| TD Asset Management Inc | 53,956 | $566.5K | 0.00% | +53,956 | New |
| Bank of New York Mellon Corp | 50,096 | $526.0K | 0.00% | −240−0.5% | Reduced |
| Nuveen Asset Management, LLC | 49,039 | $515.0K | 0.00% | −12,685−20.6% | Reduced |
| Charles Schwab Investment Management Inc | 47,807 | $502.0K | 0.00% | +804+1.7% | Added |
| Manufacturers Life Insurance Company, The | 42,585 | $442.3K | 0.00% | +42,585 | New |
| Barclays PLC | 36,519 | $383.5K | 0.00% | −5,525−13.1% | Reduced |
| Bank of America Corp | 27,215 | $285.8K | 0.00% | −18,024−39.8% | Reduced |
| Bank of Montreal | 19,429 | $273.8K | 0.00% | +19,429 | New |
| Alps Advisors Inc | 24,432 | $256.5K | 0.00% | +24,432 | New |
| Water Island Capital LLC | 23,500 | $246.8K | 0.02% | +12,800+119.6% | Added |
| Rhumbline Advisers | 22,670 | $238.0K | 0.00% | +331+1.5% | Added |
| Alyeska Investment Group, L.P. | 21,456 | $225.3K | 0.00% | +21,456 | New |
| New York State Common Retirement Fund | 14,462 | $151.9K | 0.00% | −10−0.1% | Reduced |
| Renaissance Technologies LLC | 13,100 | $138.0K | 0.00% | +13,100 | New |
| CVI Holdings, LLC | 12,592 | $132.2K | 0.02% | +12,592 | New |
| MetLife Investment Management | 11,026 | $115.8K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 10,746 | $113.0K | 0.00% | +733+7.3% | Added |
| American International Group, Inc. | 8,668 | $91.0K | 0.00% | −32−0.4% | Reduced |
| Deutsche Bank AG | 8,159 | $85.7K | 0.00% | +124+1.5% | Added |
| California State Teachers Retirement System | 7,316 | $76.8K | 0.00% | +83+1.1% | Added |
| Tower Research Capital LLC (TRC) | 3,535 | $37.0K | 0.00% | +2,273+180.1% | Added |
| Amalgamated Bank | 2,941 | $31.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,681 | $28.0K | 0.00% | +2,458+1,102.2% | Added |
| Legal & General Group Plc | 2,256 | $23.7K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 1,374 | $14.6K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,280 | $13.4K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,104 | $11.6K | 0.00% | −11,163−91.0% | Reduced |
| Credit Suisse AG | 1 | $11 | 0.00% | −102−99.0% | Reduced |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −13,414−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −12,430−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,961−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −5,821−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −310−100.0% | Sold out |